Dr. Benjamin Medina is a thoracic surgeon at the Rutgers Cancer Institute of New Jersey and RWJBarnabas Health. He specializes in thoracic malignancies including lung cancer and malignant pleural mesothelioma, as well as esophageal cancer, mediastinal tumors, and chest wall tumors, using robotic and minimally invasive techniques that minimize pain, shorten hospital stays, and provide
While malignant mesothelioma remains a fatal diagnosis, innovations in surgical techniques and other treatments have made a significant impact on overall survival and quality of life. A recent study conducted by researchers from Kaiser Permanente in Northern California confirmed that increased specialization of mesothelioma physicians and the use of bi-disciplinary tumor boards makes a significant
Dr. Konstantin H. Dragnev is a medical oncologist and renowned researcher at the Dartmouth Cancer Center. His principal clinical focus is on improving outcomes for patients diagnosed with non-small cell and small cell lung cancer, malignant pleural mesothelioma, and esophageal cancer using molecularly targeted therapies. Dr. Dragnev is also a professor of medicine at Dartmouth’s
Dr. Rian M. Hasson is a thoracic surgeon at the Dartmouth Cancer Center and Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire and Assistant Professor of Surgery at the Geisel School of Medicine at Dartmouth. She works as part of a multidisciplinary team to treat patients diagnosed with a range of thoracic cancers and benign diseases,
David J. Finley is the Program Director of Dartmouth Cancer Center’s Comprehensive Thoracic Oncology Program. A thoracic surgeon triple board certified in Surgery, General Surgery, and Thoracic and Cardiac Surgery, he is skilled in a wide range of surgical techniques. He specializes in the treatment of patients with malignant pleural mesothelioma, lung cancer, esophageal cancer,
Dr. Estelamari Rodriguez is a triple board-certified hematologist, oncologist, and internist at the University of Miami’s Sylvester Comprehensive Cancer Center. Her clinical interest is in the early detection and treatment of malignant mesothelioma and lung cancer, as well as in developing programs to eradicate disparities in health care. In addition to the care she provides
Dr. Apar Kishor Ganti is an oncologist and internal medicine specialist at the University of Nebraska Medical Center. He is a physician scientist whose primary interests are lung cancer, malignant pleural mesothelioma, thymoma, head and neck cancers, and thyroid cancers. Dr. Ganti is also an integral member of the Omaha VA Medical Center’s care team,
Malignant mesothelioma and asbestos-related lung cancer are common causes of death among people who work in asbestos-contaminated work settings. There are several legal and financial remedies available to those who’ve been affected by these circumstances, ranging from personal injury litigation to filing for workers’ compensation benefits, and all-too-frequently companies object to being held responsible, no
Dr. Laxmi Narayana R. Buddharaju is a medical oncologist and hematologist at Great Plains Health in North Platte, Nebraska. He spent much of his career at the University of Nebraska Medical Center, seeing patients and serving as an Assistant Professor in the Department of Internal Medicine, Division of Oncology/Hematology at the College of Medicine. He
Dr. Erik Lewis is a thoracic and cardiothoracic surgeon at the University of Nebraska Medical Center and the Fred and Pamela Buffett Cancer Center in Omaha, Nebraska. He treats a wide variety of conditions ranging from lung and esophageal cancers and other thoracic malignancies like malignant pleural mesothelioma. He also treats patients diagnosed with benign conditions